You are here
Department of Neurosciences; Psychology; Drug Research and Child Health (NEUROFARBA); University of Florence
Areas of Interest:
Alzheimer’s disease, frontotemporal dementia, biomarkers, sleep, neuroimaging, neuropsychology, cognitive reserve
Biography & Research:
Gemma Lombardi is Postdoctoral Research Fellow at the University of Florence and teacher of Neurology in the International College of Osteopathic Medicine, Florence. She licensed to practice Medicine in 2007 and achieved the specialization in Neurology at the University of Florence, with Professor S. Sorbi, in 2012. In 2016 she achieved the PhD in Neurosciences at the same University. Since 2006 she has been studying sleep disturbances in patients affected by cognitive impairments and the relation between sleep and dementia. She is co-author of the review “Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia (Neurol Sci, 2014). During the specialization she focused her attention on the effect of cognitive reserve in delaying dementia. Moreover, she spent 4 months research fellow at the Nuclear Medicine Department in Lipsia, training with Professor H. Barthel and O. Sabri in the use of imaging software to detect amyloid burden in patients with Alzheimer’s Disease and Down Syndrome. During the PhD in Neurosciences she focused her studies on biomarkers in dementia and subsequently proposed a proof of a diagnostic work-up to apply in atypical dementia cases (Neurol Sci, 2018). Actually, she is consultant for the IRCCS Carlo Besta, Milano for the realization of a project funded by Ministry of Health focused on the implementation and evaluation of an integrated care pathway for dementia in the National Health Service of five Italian regions. Since 2012 she is engaged in many national and international studies: “Italian Network for autosomal dominant Alzheimer’s disease and frontotemporal lobar degeneration", “GENetic Frontotemporal Dementia Initiative (GENFI 1 and GENFI2)”, trials of active and passive immunotherapies for the treatment of Alzheimer's disease, observational studies focused on sleep quality and genetic aspects in patients affected by Alzheimer’s Disease and Mild Cognitive Impairment (MCI). In the last year she concentrates her attention on the prevention strategies implementing enrolment in the project “Games for Olders Active Life” in collaboration with the IRCCS Fondazione Don Carlo Gnocchi, Florence.